Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Current value sales of sleep aids continue to rise in 2023, albeit at a slower rate due to stocking up and strong sales over the last three years since the emergence of the pandemic. Local consumers continue to experience the cost-of-living crisis in…
Sports nutrition witnessed an upturn in current value sales in 2022 as consumers left COVID-19 fears behind and returned to gyms and their usual sporting activities. Moving into 2023, Many Costa Ricans focus on losing weight gained during the…
After a marginal decline in the first year of the pandemic, sports nutrition in the UK continues to record strong current value sales growth in 2023, following a full recovery in 2021. Apart from the price hikes driven by inflation since the end of…
Consumers having less disposable income has impacted their purchasing habits in 2023, including their choices regarding healthcare products and vitamins. Rather than investing in preventative measures like vitamins, consumers are opting for more…
Value sales of vitamins have rebounded in 2023, recording growth for the first time since 2021. Although value growth is much weaker than at the height of the pandemic, and overall retail volume sales are continuing to decline, demand remains above…
During 2022 and 2023, Ozempic injections have started to be used by consumers who do not have type 2 diabetes to lose weight. Popularised by international media, higher-income consumers who can afford them have resorted to using these injections to…
Weight management and wellbeing continues to experience strong value growth in 2023, as the general health and wellness trend remains prevalent post-pandemic. As consumers have returned to hectic routines with the reopening of offices, balancing a…
The growth of sports and indoor and outdoor activities, as well as children returning to school, has led to increased injuries compared to the previous years of COVID-19 restrictions. This, in turn, has driven the demand for first aid products in…
With a lack of new product development and brand activity in 2023, demand for wound care is being primarily driven by a full year without lockdown restrictions boosting out-of-home activities. The category’s performance is largely dependent on…
While analgesics are expected to register double-digit current value growth, constant value and volume growth is expected to be much more moderate, as inflation continues to be high. Any growth there is Chufa supported by population growth, as well…
Retail volume sales of analgesics rebounded in 2023, following a two-year period of decline. While the COVID-19 pandemic boosted demand for acetaminophen (paracetamol), which was the only analgesic recommended by the government to alleviate the…
Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…
While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…
Analgesics achieved strong double-digit growth in 2023 amidst stable consumer demand and rising unit prices caused by inflation. Systemic analgesics is outperforming topical analgesics in 2023, a trend that has been prevalent throughout the review…
Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…
In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…
Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…
After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…
Growth of analgesics in 2023 can be mainly attributed to the full recovery of daily activity post pandemic. The main contributors here were the full operation of manual labour intensive industries (predominantly construction), a stronger flu season…
Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…